A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects

Clinical trial NCT01806324 · COMPLETED

Trial details

NCT number: NCT01806324
Sponsor: HanAll BioPharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension Hyperlipidemia

Start date: 2012-04-01
Primary completion: 2012-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.